 | • レポートコード：MRC2102QY0422 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のアルブミン（賦形剤）市場について種類別（ヒト血清アルブミン、組換えアルブミン）、用途別（細胞培養培地、医療用サプリメント、治療薬）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・アルブミン（賦形剤）市場の概要 ・世界の主要地域別アルブミン（賦形剤）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のアルブミン（賦形剤）市場規模2015-2026：種類別（ヒト血清アルブミン、組換えアルブミン） ・世界のアルブミン（賦形剤）市場規模2015-2026：用途別（細胞培養培地、医療用サプリメント、治療薬） ・アルブミン（賦形剤）の米国市場規模2015-2020 ・アルブミン（賦形剤）のヨーロッパ市場規模2015-2020 ・アルブミン（賦形剤）の中国市場規模2015-2020 ・アルブミン（賦形剤）の日本市場規模2015-2020 ・アルブミン（賦形剤）の東南アジア市場規模2015-2020 ・アルブミン（賦形剤）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・アルブミン（賦形剤）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・アルブミン（賦形剤）の市場動向・機会・課題 ・調査の結論 |
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry’s leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Market Analysis and Insights: Global Albumin (as Excipient) Market
The global Albumin (as Excipient) market size is projected to reach US$ 5835.9 million by 2026, from US$ 4095.5 million in 2020, at a CAGR of 6.1% during 2021-2026.
Global Albumin (as Excipient) Scope and Market Size
The global Albumin (as Excipient) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Albumin (as Excipient) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Albumin (as Excipient) market is segmented into
Human Serum Albumin
Recombinant Albumin
In terms of type, Human Serum Albumin has the highest proportion of revenue, exceeding 98% in 2019.
Segment by Application, the Albumin (as Excipient) market is segmented into
Cell Culture Media
Medical Supplements
Therapeutics
Therapeutics had the highest share of sales by application, at 73.27% in 2019.
The Albumin (as Excipient) market is analysed and market size information is provided by regions (countries). Segment by Application, the Albumin (as Excipient) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Albumin (as Excipient) Market Share Analysis
Albumin (as Excipient) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Albumin (as Excipient) business, the date to enter into the Albumin (as Excipient) market, Albumin (as Excipient) product introduction, recent developments, etc.
The major vendors covered:
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
1 Albumin (as Excipient) Market Overview
1.1 Albumin (as Excipient) Product Scope
1.2 Albumin (as Excipient) Segment by Type
1.2.1 Global Albumin (as Excipient) Sales by Type (2020-2026)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Albumin (as Excipient) Segment by Application
1.3.1 Global Albumin (as Excipient) Sales Comparison by Application (2020-2026)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Albumin (as Excipient) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Albumin (as Excipient) Sales Growth Rate (2015-2026)
1.4.2 Global Albumin (as Excipient) Revenue and Growth Rate (2015-2026)
1.4.3 Global Albumin (as Excipient) Price Trends (2015-2026)
2 Albumin (as Excipient) Estimate and Forecast by Region
2.1 Global Albumin (as Excipient) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Albumin (as Excipient) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Albumin (as Excipient) Sales Market Share by Region (2015-2020)
2.2.2 Global Albumin (as Excipient) Revenue Market Share by Region (2015-2020)
2.3 Global Albumin (as Excipient) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Albumin (as Excipient) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Albumin (as Excipient) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Albumin (as Excipient) Estimates and Projections (2015-2026)
2.4.2 Europe Albumin (as Excipient) Estimates and Projections (2015-2026)
2.4.3 China Albumin (as Excipient) Estimates and Projections (2015-2026)
2.4.4 Japan Albumin (as Excipient) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Albumin (as Excipient) Estimates and Projections (2015-2026)
2.4.6 India Albumin (as Excipient) Estimates and Projections (2015-2026)
3 Global Albumin (as Excipient) Competition Landscape by Players
3.1 Global Top Albumin (as Excipient) Players by Sales (2015-2020)
3.2 Global Top Albumin (as Excipient) Players by Revenue (2015-2020)
3.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Albumin (as Excipient) as of 2019)
3.4 Global Albumin (as Excipient) Average Price by Company (2015-2020)
3.5 Manufacturers Albumin (as Excipient) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Albumin (as Excipient) Players (Opinion Leaders)
4 Global Albumin (as Excipient) Market Size by Type
4.1 Global Albumin (as Excipient) Historic Market Review by Type (2015-2020)
4.1.1 Global Albumin (as Excipient) Sales Market Share by Type (2015-2020)
4.1.2 Global Albumin (as Excipient) Revenue Market Share by Type (2015-2020)
4.1.3 Global Albumin (as Excipient) Price by Type (2015-2020)
4.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Albumin (as Excipient) Sales Forecast by Type (2021-2026)
4.2.2 Global Albumin (as Excipient) Revenue Forecast by Type (2021-2026)
4.2.3 Global Albumin (as Excipient) Price Forecast by Type (2021-2026)
5 Global Albumin (as Excipient) Market Size by Application
5.1 Global Albumin (as Excipient) Historic Market Review by Application (2015-2020)
5.1.1 Global Albumin (as Excipient) Sales Market Share by Application (2015-2020)
5.1.2 Global Albumin (as Excipient) Revenue Market Share by Application (2015-2020)
5.1.3 Global Albumin (as Excipient) Price by Application (2015-2020)
5.2 Global Albumin (as Excipient) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Albumin (as Excipient) Sales Forecast by Application (2021-2026)
5.2.2 Global Albumin (as Excipient) Revenue Forecast by Application (2021-2026)
5.2.3 Global Albumin (as Excipient) Price Forecast by Application (2021-2026)
6 United States Albumin (as Excipient) Market Facts & Figures
6.1 United States Albumin (as Excipient) Sales Market Share by Company (2015-2020)
6.2 United States Albumin (as Excipient) Sales Market Share by Type (2015-2020)
6.3 United States Albumin (as Excipient) Sales Market Share by Application (2015-2020)
7 Europe Albumin (as Excipient) Market Facts & Figures
7.1 Europe Albumin (as Excipient) Sales Market Share by Company (2015-2020)
7.2 Europe Albumin (as Excipient) Sales Market Share by Type (2015-2020)
7.3 Europe Albumin (as Excipient) Sales Market Share by Application (2015-2020)
8 China Albumin (as Excipient) Market Facts & Figures
8.1 China Albumin (as Excipient) Sales Market Share by Company (2015-2020)
8.2 China Albumin (as Excipient) Sales Market Share by Type (2015-2020)
8.3 China Albumin (as Excipient) Sales Market Share by Application (2015-2020)
9 Japan Albumin (as Excipient) Market Facts & Figures
9.1 Japan Albumin (as Excipient) Sales Market Share by Company (3015-3030)
9.2 Japan Albumin (as Excipient) Sales Market Share by Type (2015-2020)
9.3 Japan Albumin (as Excipient) Sales Market Share by Application (2015-2020)
10 Southeast Asia Albumin (as Excipient) Market Facts & Figures
10.1 Southeast Asia Albumin (as Excipient) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Albumin (as Excipient) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Albumin (as Excipient) Sales Market Share by Application (2015-2020)
11 India Albumin (as Excipient) Market Facts & Figures
11.1 India Albumin (as Excipient) Sales Market Share by Company (2015-2020)
11.2 India Albumin (as Excipient) Sales Market Share by Type (2015-2020)
11.3 India Albumin (as Excipient) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Albumin (as Excipient) Business
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Business Overview
12.1.3 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Albumin (as Excipient) Products Offered
12.1.5 CSL Recent Development
12.2 Grifols
12.2.1 Grifols Corporation Information
12.2.2 Grifols Business Overview
12.2.3 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Grifols Albumin (as Excipient) Products Offered
12.2.5 Grifols Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Takeda Albumin (as Excipient) Products Offered
12.3.5 Takeda Recent Development
12.4 Octapharma
12.4.1 Octapharma Corporation Information
12.4.2 Octapharma Business Overview
12.4.3 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Octapharma Albumin (as Excipient) Products Offered
12.4.5 Octapharma Recent Development
12.5 Hualan Bio
12.5.1 Hualan Bio Corporation Information
12.5.2 Hualan Bio Business Overview
12.5.3 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hualan Bio Albumin (as Excipient) Products Offered
12.5.5 Hualan Bio Recent Development
12.6 CBPO
12.6.1 CBPO Corporation Information
12.6.2 CBPO Business Overview
12.6.3 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 CBPO Albumin (as Excipient) Products Offered
12.6.5 CBPO Recent Development
12.7 Shanghai RAAS
12.7.1 Shanghai RAAS Corporation Information
12.7.2 Shanghai RAAS Business Overview
12.7.3 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Shanghai RAAS Albumin (as Excipient) Products Offered
12.7.5 Shanghai RAAS Recent Development
12.8 Kedrion
12.8.1 Kedrion Corporation Information
12.8.2 Kedrion Business Overview
12.8.3 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Kedrion Albumin (as Excipient) Products Offered
12.8.5 Kedrion Recent Development
12.9 LFB Group
12.9.1 LFB Group Corporation Information
12.9.2 LFB Group Business Overview
12.9.3 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 LFB Group Albumin (as Excipient) Products Offered
12.9.5 LFB Group Recent Development
12.10 Albumedix
12.10.1 Albumedix Corporation Information
12.10.2 Albumedix Business Overview
12.10.3 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Albumedix Albumin (as Excipient) Products Offered
12.10.5 Albumedix Recent Development
12.11 Biotest
12.11.1 Biotest Corporation Information
12.11.2 Biotest Business Overview
12.11.3 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Biotest Albumin (as Excipient) Products Offered
12.11.5 Biotest Recent Development
12.12 Merck
12.12.1 Merck Corporation Information
12.12.2 Merck Business Overview
12.12.3 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Merck Albumin (as Excipient) Products Offered
12.12.5 Merck Recent Development
12.13 Ventria (InVitria)
12.13.1 Ventria (InVitria) Corporation Information
12.13.2 Ventria (InVitria) Business Overview
12.13.3 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Ventria (InVitria) Albumin (as Excipient) Products Offered
12.13.5 Ventria (InVitria) Recent Development
12.14 HiMedia
12.14.1 HiMedia Corporation Information
12.14.2 HiMedia Business Overview
12.14.3 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2015-2020)
12.14.4 HiMedia Albumin (as Excipient) Products Offered
12.14.5 HiMedia Recent Development
13 Albumin (as Excipient) Manufacturing Cost Analysis
13.1 Albumin (as Excipient) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Albumin (as Excipient)
13.4 Albumin (as Excipient) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Albumin (as Excipient) Distributors List
14.3 Albumin (as Excipient) Customers
15 Market Dynamics
15.1 Albumin (as Excipient) Market Trends
15.2 Albumin (as Excipient) Opportunities and Drivers
15.3 Albumin (as Excipient) Market Challenges
15.4 Albumin (as Excipient) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Albumin (as Excipient) Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Albumin (as Excipient) Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Albumin (as Excipient) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Albumin (as Excipient) Sales (MT) by Region (2015-2020)
Table 5. Global Albumin (as Excipient) Sales Market Share by Region (2015-2020)
Table 6. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Albumin (as Excipient) Revenue Share by Region (2015-2020)
Table 8. Global Albumin (as Excipient) Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Albumin (as Excipient) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Albumin (as Excipient) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Albumin (as Excipient) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Albumin (as Excipient) (MT) of Key Companies (2015-2020)
Table 13. Global Albumin (as Excipient) Sales Share by Company (2015-2020)
Table 14. Global Albumin (as Excipient) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Albumin (as Excipient) Revenue Share by Company (2015-2020)
Table 16. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Albumin (as Excipient) as of 2019)
Table 17. Global Albumin (as Excipient) Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Albumin (as Excipient) Manufacturing Sites and Area Served
Table 19. Manufacturers Albumin (as Excipient) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Albumin (as Excipient) Players
Table 22. Global Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 23. Global Albumin (as Excipient) Sales Share by Type (2015-2020)
Table 24. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Albumin (as Excipient) Price (MT) by Type (2015-2020)
Table 26. Global Albumin (as Excipient) Sales Share by Type (2021-2026)
Table 27. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Albumin (as Excipient) Revenue Share by Type (2021-2026)
Table 29. Global Albumin (as Excipient) Price (MT) by Type (2021-2026)
Table 30. Global Albumin (as Excipient) Sales (MT) by Application (2015-2020)
Table 31. Global Albumin (as Excipient) Sales Share by Application (2015-2020)
Table 32. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Albumin (as Excipient) Price (MT) by Application (2015-2020)
Table 34. Global Albumin (as Excipient) Sales (MT) by Application (2021-2026)
Table 35. Global Albumin (as Excipient) Sales Share by Application (2021-2026)
Table 36. Global Albumin (as Excipient) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Albumin (as Excipient) Revenue Share by Application (2021-2026)
Table 38. Global Albumin (as Excipient) Price (MT) by Application (2021-2026)
Table 39. United States Albumin (as Excipient) Sales (MT) by Company (2015-2020)
Table 40. United States Albumin (as Excipient) Sales Market Share by Company (2015-2020)
Table 41. United States Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 42. United States Albumin (as Excipient) Sales Market Share by Type (2015-2020)
Table 43. United States Albumin (as Excipient) Sales (MT) by Application (2015-2020)
Table 44. United States Albumin (as Excipient) Sales Market Share by Application (2015-2020)
Table 45. Europe Albumin (as Excipient) Sales (MT) by Company (2015-2020)
Table 46. Europe Albumin (as Excipient) Sales Market Share by Company (2015-2020)
Table 47. Europe Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 48. Europe Albumin (as Excipient) Sales Market Share by Type (2015-2020)
Table 49. Europe Albumin (as Excipient) Sales (MT) by Application (2015-2020)
Table 50. Europe Albumin (as Excipient) Sales Market Share by Type (2015-2020)
Table 51. China Albumin (as Excipient) Sales (MT) by Company (2015-2020)
Table 52. China Albumin (as Excipient) Sales Market Share by Company (2015-2020)
Table 53. China Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 54. China Albumin (as Excipient) Sales Market Share by Type (2015-2020)
Table 55. China Albumin (as Excipient) Sales (MT) by Application (2015-2020)
Table 56. China Albumin (as Excipient) Sales Market Share by Application (2015-2020)
Table 57. Japan Albumin (as Excipient) Sales (MT) by Company (2015-2020)
Table 58. Japan Albumin (as Excipient) Sales Market Share by Company (2015-2020)
Table 59. Japan Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 60. Japan Albumin (as Excipient) Sales Market Share by Type (2015-2020)
Table 61. Japan Albumin (as Excipient) Sales (MT) by Application (2015-2020)
Table 62. Japan Albumin (as Excipient) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Albumin (as Excipient) Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Albumin (as Excipient) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Albumin (as Excipient) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Albumin (as Excipient) Sales Market Share by Application (2015-2020)
Table 69. India Albumin (as Excipient) Sales (MT) by Company (2015-2020)
Table 70. India Albumin (as Excipient) Sales Market Share by Company (2015-2020)
Table 71. India Albumin (as Excipient) Sales (MT) by Type (2015-2020)
Table 72. India Albumin (as Excipient) Sales Market Share by Type (2015-2020)
Table 73. India Albumin (as Excipient) Sales (MT) by Application (2015-2020)
Table 74. India Albumin (as Excipient) Sales Market Share by Application (2015-2020)
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. CSL Albumin (as Excipient) Product
Table 79. CSL Recent Development
Table 80. Grifols Corporation Information
Table 81. Grifols Description and Business Overview
Table 82. Grifols Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Grifols Albumin (as Excipient) Product
Table 84. Grifols Recent Development
Table 85. Takeda Corporation Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Takeda Albumin (as Excipient) Product
Table 89. Takeda Recent Development
Table 90. Octapharma Corporation Information
Table 91. Octapharma Description and Business Overview
Table 92. Octapharma Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Octapharma Albumin (as Excipient) Product
Table 94. Octapharma Recent Development
Table 95. Hualan Bio Corporation Information
Table 96. Hualan Bio Description and Business Overview
Table 97. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Hualan Bio Albumin (as Excipient) Product
Table 99. Hualan Bio Recent Development
Table 100. CBPO Corporation Information
Table 101. CBPO Description and Business Overview
Table 102. CBPO Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. CBPO Albumin (as Excipient) Product
Table 104. CBPO Recent Development
Table 105. Shanghai RAAS Corporation Information
Table 106. Shanghai RAAS Description and Business Overview
Table 107. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Shanghai RAAS Albumin (as Excipient) Product
Table 109. Shanghai RAAS Recent Development
Table 110. Kedrion Corporation Information
Table 111. Kedrion Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Kedrion Description and Business Overview
Table 113. Kedrion Albumin (as Excipient) Product
Table 114. Kedrion Recent Development
Table 115. LFB Group Corporation Information
Table 116. LFB Group Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. LFB Group Description and Business Overview
Table 118. LFB Group Albumin (as Excipient) Product
Table 119. LFB Group Recent Development
Table 120. Albumedix Corporation Information
Table 121. Albumedix Description and Business Overview
Table 122. Albumedix Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. Albumedix Albumin (as Excipient) Product
Table 124. Albumedix Recent Development
Table 125. Biotest Corporation Information
Table 126. Biotest Description and Business Overview
Table 127. Biotest Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Biotest Albumin (as Excipient) Product
Table 129. Biotest Recent Development
Table 130. Merck Corporation Information
Table 131. Merck Description and Business Overview
Table 132. Merck Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Merck Albumin (as Excipient) Product
Table 134. Merck Recent Development
Table 135. Ventria (InVitria) Corporation Information
Table 136. Ventria (InVitria) Description and Business Overview
Table 137. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Ventria (InVitria) Albumin (as Excipient) Product
Table 139. Ventria (InVitria) Recent Development
Table 140. HiMedia Corporation Information
Table 141. HiMedia Description and Business Overview
Table 142. HiMedia Albumin (as Excipient) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. HiMedia Albumin (as Excipient) Product
Table 144. HiMedia Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Albumin (as Excipient) Distributors List
Table 148. Albumin (as Excipient) Customers List
Table 149. Albumin (as Excipient) Market Key Trends
Table 150. Albumin (as Excipient) Key Opportunities and Drivers
Table 151. Albumin (as Excipient) Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Albumin (as Excipient) Product Picture
Figure 2. Global Albumin (as Excipient) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Albumin (as Excipient) Market Share by Application in 2020 & 2026
Figure 6. Cell Culture Media Examples
Figure 7. Medical Supplements Examples
Figure 8. Therapeutics Examples
Figure 9. Global Albumin (as Excipient) Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Albumin (as Excipient) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Albumin (as Excipient) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Albumin (as Excipient) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Albumin (as Excipient) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Albumin (as Excipient) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Albumin (as Excipient) Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Albumin (as Excipient) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Albumin (as Excipient) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Albumin (as Excipient) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Albumin (as Excipient) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Albumin (as Excipient) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Albumin (as Excipient) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Albumin (as Excipient) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Albumin (as Excipient) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Albumin (as Excipient) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Albumin (as Excipient) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Albumin (as Excipient) Players Market Share by Revenue in Albumin (as Excipient) 2015 & 2019
Figure 27. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Albumin (as Excipient) Revenue Share by Type (2015-2020)
Figure 29. Global Albumin (as Excipient) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Albumin (as Excipient) Revenue Share by Application (2015-2020)
Figure 31. Global Albumin (as Excipient) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Albumin (as Excipient) Sales Market Share by Type in 2019
Figure 33. United States Albumin (as Excipient) Sales Market Share by Type in 2019
Figure 34. Europe Albumin (as Excipient) Sales Market Share by Company in 2019
Figure 35. Europe Albumin (as Excipient) Sales Market Share by Type in 2019
Figure 36. Europe Albumin (as Excipient) Sales Market Share by Application in 2019
Figure 37. China Albumin (as Excipient) Sales Market Share by Company in 2019
Figure 38. China Albumin (as Excipient) Sales Market Share by Type in 2019
Figure 39. China Albumin (as Excipient) Sales Market Share by Application in 2019
Figure 40. Japan Albumin (as Excipient) Sales Market Share by Company in 2019
Figure 41. Japan Albumin (as Excipient) Sales Market Share by Type in 2019
Figure 42. Japan Albumin (as Excipient) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Albumin (as Excipient) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Albumin (as Excipient) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Albumin (as Excipient) Sales Market Share by Application in 2019
Figure 46. India Albumin (as Excipient) Sales Market Share by Company in 2019
Figure 47. India Albumin (as Excipient) Sales Market Share by Type in 2019
Figure 48. India Albumin (as Excipient) Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Albumin (as Excipient)
Figure 51. Manufacturing Process Analysis of Albumin (as Excipient)
Figure 52. Albumin (as Excipient) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
組換えヒト血清アルブミンの世界市場レポート2020 Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression syste…- アルブミンの世界市場レポート2020 Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses. China is the …
- 治療用組換えタンパク質の世界市場レポート2020 Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vector…
- 組織培養用試薬の世界市場レポート2020 Market Analysis and Insights: Global Tissue Culture Reagent Market The global Tissue Culture Reagent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tissue Culture Reagent Scope and Market Size The global Tissue Culture…
- ウシ血漿誘導体の世界市場レポート2020 Bovine Blood Plasma Derivatives covers different types of bovine blood plasma derivatives,and typically used in scientific research and industrial production. Thermo Fisher, GE Healthcare, Merck (Sigma-Aldrich), Moregate BioTech, Gemini, Atlanta Biologicals, Tissue Culture Biologicals and Bovogen ar…